NEWS

Recently, Haier Biomedical has achieved significant success in the Southeast Asian market, with 5 Blood Banking Centrifuges successfully installed at Hospital R, the largest hospital in Ho Chi Minh City, Vietnam. This breakthrough not only demonstrates Haier Biomedical's strong presence in the Vietnamese market but also signifies that high-end equipment from "Intelligent Manufacturing in China" is deeply integrating into and promoting the modernization of Vietnam's healthcare system.

Recently, China's independently developed nine-valent HPV vaccine has been officially put into use, marking a new stage in HPV prevention and control in China and providing more comprehensive and accessible protection options for women aged 9 to 45.

Recently, Haier Biomedical marked another milestone in its globalization journey—its medical cold chain solutions have successfully entered the core application scenarios of the U.S. Department of Veterans Affairs Hospital (VA Hospital) and the University of California, Davis (UC Davis). This is the first time China's high-end medical equipment has been deployed in the core settings of leading U.S. medical and research institutions, marking that Haier Biomedical's "Chinese Solution" has earned recognition in one of the world's most demanding markets, setting a new global benchmark for the globalization of smart healthcare.

"Health, Innovation, Collaboration—Co-Creating a New Blueprint for Global Healthcare."

92nd China International Medical Equipment Fair (CMEF) recently opened to great anticipation. As the industry's large-scale and influential event, this year's CMEF gathered cutting-edge technologies and pioneering ideas from around the world, injecting strong momentum into global healthcare development. 

At this industry event, Haier Biomedical, a leader in life sciences and medical innovation under Incaier, made a high-profile appearance. With a strong lineup of highlight products, the company delivered a comprehensive showcase of solutions spanning multiple scenarios and the entire value chain, becoming a defining presence on the exhibition floor.

Recently, Haier Biomedical, together with its U.S. strategic partner Apostle, officially unveiled its first show room in Pleasanton, California. This milestone not only stands as a powerful testament to the deepening partnership between the two sides, but also represents a pivotal move in Haier Biomedical's strategy for the North American market, marking a new chapter in its regional expansion.

Recently, a client who sells frozen bovine semen shared a persistent pain point: when using conventional liquid nitrogen containers for storage, the positioning plates inside his containers acted like "invisible killers", snagging and tearing the cloth bags during handling, resulting in lost or damaged samples and costly business development disruptions.

When the client was at a loss, an industry peer recommended Haier Biomedical's Livestock Liquid Nitrogen Container that is purpose-built to resolve livestock industry's pain points. The client immediately contacted the company for a closer look, eager to find the optimal solution.

In Bangkok's year-round hot and humid climate, Haier Biomedical's two Cold Rooms—operating at -20ºC and 4ºC—have run stably for over 400 days without a single failure. These facilities have become the benchmark of tropical medical cold chains, earning high praise from users.

Against the backdrop of Southeast Asia's booming medical and healthcare industry and surging demand for specialized, intelligent medical products, high-quality medical capabilities have become the driving force for new development momentum. Haier Biomedical recently visited Thailand, engaging in strategic dialogues with leading medical institutions to jointly envision the future of smart healthcare.